Catalyst Pharmaceuticals, Inc. (CPRX)
USD 23.18
(-3.86%)
USD 23.18
(-3.86%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -134.07 Million USD | 54.47% |
| 2022 | -294.5 Million USD | -75.77% |
| 2021 | -167.55 Million USD | -28.68% |
| 2020 | -130.2 Million USD | -46.53% |
| 2019 | -88.86 Million USD | -436.64% |
| 2018 | -16.55 Million USD | 71.2% |
| 2017 | -57.49 Million USD | -313.85% |
| 2016 | -13.89 Million USD | 50.79% |
| 2015 | -28.23 Million USD | -210.38% |
| 2014 | -9.09 Million USD | -310.51% |
| 2013 | -2.21 Million USD | -57.17% |
| 2012 | -1.4 Million USD | 76.61% |
| 2011 | -6.02 Million USD | -10.12% |
| 2010 | -5.47 Million USD | 29.62% |
| 2009 | -7.77 Million USD | 33.89% |
| 2008 | -11.76 Million USD | 26.2% |
| 2007 | -15.94 Million USD | 21.98% |
| 2006 | -20.43 Million USD | -2549.98% |
| 2005 | -771.12 Thousand USD | -319.29% |
| 2004 | -183.91 Thousand USD | 0.0% |
| 2002 | -107.08 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -372.31 Million USD | -21.3% |
| 2024 Q1 | -306.94 Million USD | -128.93% |
| 2023 Q2 | -175.05 Million USD | -20.91% |
| 2023 FY | -134.07 Million USD | 54.47% |
| 2023 Q1 | -144.77 Million USD | 50.84% |
| 2023 Q4 | -134.07 Million USD | -14.28% |
| 2023 Q3 | -117.32 Million USD | 32.98% |
| 2022 Q1 | -174.24 Million USD | -3.99% |
| 2022 FY | -294.5 Million USD | -75.77% |
| 2022 Q2 | -206.86 Million USD | -18.72% |
| 2022 Q3 | -252.09 Million USD | -21.87% |
| 2022 Q4 | -294.5 Million USD | -16.82% |
| 2021 Q2 | -131.04 Million USD | -6.47% |
| 2021 Q1 | -123.07 Million USD | 5.48% |
| 2021 FY | -167.55 Million USD | -28.68% |
| 2021 Q3 | -150.58 Million USD | -14.91% |
| 2021 Q4 | -167.55 Million USD | -11.27% |
| 2020 Q2 | -114.85 Million USD | -13.86% |
| 2020 FY | -130.2 Million USD | -46.53% |
| 2020 Q4 | -130.2 Million USD | -11.3% |
| 2020 Q3 | -116.99 Million USD | -1.86% |
| 2020 Q1 | -100.87 Million USD | -13.52% |
| 2019 Q1 | -18.2 Million USD | -9.95% |
| 2019 Q2 | -22.32 Million USD | -22.64% |
| 2019 Q3 | -43.96 Million USD | -96.9% |
| 2019 FY | -88.86 Million USD | -436.64% |
| 2019 Q4 | -88.86 Million USD | -102.13% |
| 2018 Q1 | -19.6 Million USD | 65.91% |
| 2018 FY | -16.55 Million USD | 71.2% |
| 2018 Q4 | -16.55 Million USD | -55.98% |
| 2018 Q3 | -10.61 Million USD | -7.37% |
| 2018 Q2 | -9.88 Million USD | 49.55% |
| 2017 Q1 | -9.98 Million USD | 28.16% |
| 2017 FY | -57.49 Million USD | -313.85% |
| 2017 Q4 | -57.49 Million USD | -684.51% |
| 2017 Q3 | -7.32 Million USD | 14.62% |
| 2017 Q2 | -8.58 Million USD | 14.0% |
| 2016 Q1 | -22.22 Million USD | 21.28% |
| 2016 Q2 | -18.71 Million USD | 15.79% |
| 2016 Q4 | -13.89 Million USD | 21.23% |
| 2016 Q3 | -17.63 Million USD | 5.76% |
| 2016 FY | -13.89 Million USD | 50.79% |
| 2015 Q1 | -41.32 Million USD | -354.26% |
| 2015 Q2 | -37.22 Million USD | 9.93% |
| 2015 Q4 | -28.23 Million USD | 13.79% |
| 2015 FY | -28.23 Million USD | -210.38% |
| 2015 Q3 | -32.75 Million USD | 12.01% |
| 2014 Q4 | -9.09 Million USD | 19.24% |
| 2014 FY | -9.09 Million USD | -310.51% |
| 2014 Q3 | -11.26 Million USD | 23.9% |
| 2014 Q2 | -14.8 Million USD | -1280.14% |
| 2014 Q1 | -1.07 Million USD | 51.6% |
| 2013 Q4 | -2.21 Million USD | 82.91% |
| 2013 FY | -2.21 Million USD | -57.17% |
| 2013 Q3 | -12.96 Million USD | -1374.61% |
| 2013 Q2 | -879.07 Thousand USD | -36.07% |
| 2013 Q1 | -646.04 Thousand USD | 54.18% |
| 2012 FY | -1.4 Million USD | 76.61% |
| 2012 Q4 | -1.4 Million USD | 88.22% |
| 2012 Q3 | -11.97 Million USD | -59.34% |
| 2012 Q1 | -4.72 Million USD | 21.67% |
| 2012 Q2 | -7.51 Million USD | -59.12% |
| 2011 Q2 | -3.4 Million USD | 50.44% |
| 2011 Q3 | -2.15 Million USD | 36.84% |
| 2011 FY | -6.02 Million USD | -10.12% |
| 2011 Q1 | -6.87 Million USD | -25.52% |
| 2011 Q4 | -6.02 Million USD | -180.24% |
| 2010 FY | -5.47 Million USD | 29.62% |
| 2010 Q3 | -6.24 Million USD | -11.39% |
| 2010 Q1 | -6.75 Million USD | 13.13% |
| 2010 Q2 | -5.6 Million USD | 17.01% |
| 2010 Q4 | -5.47 Million USD | 12.36% |
| 2009 Q2 | -6.26 Million USD | 29.84% |
| 2009 Q3 | -4.91 Million USD | 21.6% |
| 2009 Q4 | -7.77 Million USD | -58.36% |
| 2009 FY | -7.77 Million USD | 33.89% |
| 2009 Q1 | -8.93 Million USD | 24.11% |
| 2008 Q2 | -13.08 Million USD | 11.09% |
| 2008 Q1 | -14.71 Million USD | 7.7% |
| 2008 Q4 | -11.76 Million USD | 21.7% |
| 2008 Q3 | -15.02 Million USD | -14.85% |
| 2008 FY | -11.76 Million USD | 26.2% |
| 2007 FY | -15.94 Million USD | 21.98% |
| 2007 Q1 | -19.06 Million USD | 6.7% |
| 2007 Q2 | -17.6 Million USD | 7.68% |
| 2007 Q3 | -16.88 Million USD | 4.06% |
| 2007 Q4 | -15.94 Million USD | 5.58% |
| 2006 Q2 | -324.15 Thousand USD | 0.0% |
| 2006 Q4 | -20.43 Million USD | -580.38% |
| 2006 Q3 | -3 Million USD | -826.55% |
| 2006 FY | -20.43 Million USD | -2549.98% |
| 2005 Q4 | -771.12 Thousand USD | 0.0% |
| 2005 FY | -771.12 Thousand USD | -319.29% |
| 2004 Q4 | -183.91 Thousand USD | 0.0% |
| 2004 FY | -183.91 Thousand USD | 0.0% |
| 2002 FY | -107.08 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -139.684% |
| Alkermes plc | -166.73 Million USD | 19.587% |
| Agenus Inc. | 274.13 Million USD | 148.91% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.17% |
| Aptorum Group Limited | 1.35 Million USD | 9980.21% |
| Ardelyx, Inc. | 34.51 Million USD | 488.5% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3232.687% |
| Bicycle Therapeutics plc | -481.46 Million USD | 72.152% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 470.763% |
| ChromaDex Corporation | -24.04 Million USD | -457.547% |
| Chimerix, Inc. | -25.51 Million USD | -425.45% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2024.19% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -466.284% |
| CRISPR Therapeutics AG | -150.84 Million USD | 11.115% |
| Precision BioSciences, Inc. | -85.41 Million USD | -56.983% |
| Dyadic International, Inc. | -6.37 Million USD | -2002.178% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -741.518% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1849.237% |
| Lantern Pharma Inc. | -21.7 Million USD | -517.782% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -21.298% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1469.428% |
| Incyte Corporation | -3.17 Billion USD | 95.777% |
| IO Biotech, Inc. | -140.69 Million USD | 4.705% |
| Jaguar Health, Inc. | 29.39 Million USD | 556.191% |
| Novavax, Inc. | -298.29 Million USD | 55.051% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2612.254% |
| Opthea Limited | 28.15 Million USD | 576.176% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -698.612% |
| ContextLogic Inc. | -232 Million USD | 42.207% |
| MiMedx Group, Inc. | -33.9 Million USD | -295.502% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1415.145% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5686.683% |
| NextCure, Inc. | -6.47 Million USD | -1970.079% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -165.498% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2001.881% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1202.327% |
| Vaxcyte, Inc. | -368.22 Million USD | 63.588% |
| PDS Biotechnology Corporation | -32.7 Million USD | -309.916% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 876.01% |
| Pharming Group N.V. | 109.8 Million USD | 222.108% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -670.746% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 23.484% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -623.974% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -623.974% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1788.437% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2188.038% |
| Acelyrin, Inc. | -216.9 Million USD | 38.185% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2289.886% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7677.204% |
| Summit Therapeutics Inc. | 34.67 Million USD | 486.685% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1870.88% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7805.69% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 27.371% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -73.115% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2111.795% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 134489.44% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 21450.159% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -14.552% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 20.302% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 220.934% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1665.126% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -3.845% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2044.696% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 44.678% |
| Immix Biopharma, Inc. | -17.5 Million USD | -665.737% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 57.664% |
| MEI Pharma, Inc. | -3.7 Million USD | -3518.866% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1171.689% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 182.897% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 582.42% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1849.237% |
| Precigen, Inc. | -481 Thousand USD | -27775.052% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1052.198% |
| AlloVir, Inc. | -62.69 Million USD | -113.869% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -141.089% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 317.428% |
| ImmuCell Corporation | 10.99 Million USD | 1319.947% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 13.018% |
| Onconetix, Inc. | 5.33 Million USD | 2614.875% |
| PureTech Health plc | -167.19 Million USD | 19.808% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -340.181% |
| Elevation Oncology, Inc. | -19.11 Million USD | -601.323% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2631.289% |
| Seer, Inc. | -4.24 Million USD | -3062.241% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -457.803% |
| Innoviva, Inc. | 255.56 Million USD | 152.464% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -140.01% |
| ESSA Pharma Inc. | -33.62 Million USD | -298.788% |
| GlycoMimetics, Inc. | -40.98 Million USD | -227.146% |
| GT Biopharma, Inc. | -1.02 Million USD | -13032.125% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -97.806% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 318.879% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -867.66% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -364.391% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -177879.398% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -334.447% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1536.136% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4185.018% |
| Soligenix, Inc. | -4.95 Million USD | -2607.793% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15929.87% |
| Kura Oncology, Inc. | -20.11 Million USD | -566.463% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -227.613% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1496.559% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7460.123% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4093.901% |
| Autolus Therapeutics plc | -186.59 Million USD | 28.146% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -171.943% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 51.384% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 491.266% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 181.572% |
| GRI Bio, Inc. | -1.79 Million USD | -7373.746% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1392.578% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -303.16% |
| IGM Biosciences, Inc. | -72.6 Million USD | -84.667% |
| INmune Bio, Inc. | -25.41 Million USD | -427.642% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 188.823% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -164.67% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -725.133% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4547.572% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 452.7% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -225.553% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 520.508% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 135.475% |
| Verastem, Inc. | -37.27 Million USD | -259.673% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1377.78% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -158.53% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -785.887% |
| Histogen Inc. | -7.48 Million USD | -1690.824% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -520.54% |
| Surrozen, Inc. | -32.66 Million USD | -310.479% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8797.08% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3089.708% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 807.16% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5225.344% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3326.155% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1499.769% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -208.639% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -819.807% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 57.676% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -18468.955% |
| Apollomics, Inc. | -27.39 Million USD | -389.429% |
| Amarin Corporation plc | -191.04 Million USD | 29.816% |
| Mesoblast Limited | 55.96 Million USD | 339.585% |
| Turnstone Biologics Corp. | -14.58 Million USD | -819.357% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -430.124% |
| Synaptogenix, Inc. | -28.66 Million USD | -367.802% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -14224.679% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 375.135% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15452.803% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1745.273% |
| Exelixis, Inc. | -73.05 Million USD | -83.544% |
| Better Therapeutics, Inc. | -860 Thousand USD | -15490.581% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -458.36% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 44.451% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18315.622% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1702.589% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10792.105% |
| Gritstone bio, Inc. | 39.49 Million USD | 439.526% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -59.426% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4993.916% |
| Avid Bioservices, Inc. | 169.72 Million USD | 178.996% |
| Insmed Incorporated | 721.62 Million USD | 118.58% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1366.705% |
| MediWound Ltd. | -5.32 Million USD | -2419.335% |
| OmniAb, Inc. | 9.2 Million USD | 1556.905% |
| Alector, Inc. | -35.63 Million USD | -276.235% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 255.958% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2620.759% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1112.758% |
| Zai Lab Limited | -775 Million USD | 82.699% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 139.371% |
| Aura Biosciences, Inc. | -21.52 Million USD | -522.899% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -62.559% |
| Immunic, Inc. | -45.34 Million USD | -195.719% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 30.606% |
| Veracyte, Inc. | -203.82 Million USD | 34.218% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 121.006% |
| FibroGen, Inc. | 56.76 Million USD | 336.192% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1605.66% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4642.664% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6376.158% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.921% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3913.14% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 19.212% |
| TG Therapeutics, Inc. | 17.86 Million USD | 850.638% |
| Galecto, Inc. | -21.21 Million USD | -531.971% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -463.712% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.543% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -447.887% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1065.195% |
| XBiotech Inc. | -200.02 Million USD | 32.968% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -59.426% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3061.109% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -280.226% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -73.637% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2455.983% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 21.322% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -45.148% |
| Vaxxinity, Inc. | 10.13 Million USD | 1423.322% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 118.211% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1145.214% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -103.286% |
| NexImmune, Inc. | -3.13 Million USD | -4178.694% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3783.339% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -787.268% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -394.756% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1393.741% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -107529.139% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -230.472% |
| Ainos, Inc. | 4.07 Million USD | 3387.92% |
| Pluri Inc. | 22.82 Million USD | 687.319% |
| Prothena Corporation plc | -608.34 Million USD | 77.96% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -12.903% |
| Celularity Inc. | 65.19 Million USD | 305.674% |
| Rallybio Corporation | -24.1 Million USD | -456.298% |
| Cue Biopharma, Inc. | -33.81 Million USD | -296.461% |
| MeiraGTx Holdings plc | -40.3 Million USD | -232.686% |
| Omeros Corporation | 331.17 Million USD | 140.486% |
| Humacyte, Inc. | -22.48 Million USD | -496.278% |
| Immunocore Holdings plc | -358.59 Million USD | 62.61% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -445.591% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -333.899% |
| Blueprint Medicines Corporation | 702.83 Million USD | 119.077% |
| CalciMedica, Inc. | -5.53 Million USD | -2324.575% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 28.765% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1212.698% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -234.888% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -303.209% |
| Pulmatrix, Inc. | -10.41 Million USD | -1187.117% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2143.249% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -251.526% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -20.356% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -123.674% |
| Cytokinetics, Incorporated | 642.37 Million USD | 120.872% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2202.576% |
| Nutriband Inc. | -251.65 Thousand USD | -53178.47% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -292.975% |
| Vor Biopharma Inc. | 4.3 Million USD | 3218.116% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.779% |
| Evogene Ltd. | -19.63 Million USD | -582.892% |
| ProKidney Corp. | -56.23 Million USD | -138.422% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -175.475% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1351.513% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.831% |
| CorMedix Inc. | -43.05 Million USD | -211.431% |
| BioLineRx Ltd. | 7.33 Million USD | 1927.685% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -388.181% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 390.548% |
| Atai Life Sciences N.V. | -28.55 Million USD | -369.497% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 6111.085% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -487.653% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 856.014% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -78.596% |
| MediciNova, Inc. | -50.78 Million USD | -164.021% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -70.14% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -595939.12% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1977.91% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 32.9% |
| Biomea Fusion, Inc. | -166.57 Million USD | 19.506% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 25.085% |
| Mereo BioPharma Group plc | -51.46 Million USD | -160.504% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -41.368% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 54.357% |
| Absci Corporation | -72.59 Million USD | -84.687% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3036.465% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 42.808% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -42.318% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -40.109% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -243.15% |
| Allakos Inc. | -24.97 Million USD | -436.853% |
| Imunon, Inc. | -4.21 Million USD | -3081.863% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -809.503% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 0.976% |
| BioAtla, Inc. | -109.01 Million USD | -22.996% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 18315.622% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -14178.914% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1220.5% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -532.359% |
| XOMA Corporation | -29 Million USD | -362.341% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -709.656% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1387.123% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1699.96% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -7.576% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 35.59% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -63.953% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -44.539% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -15505.388% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3387.1% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8361.743% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.71% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11184.829% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3153.496% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 218.151% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 186419.168% |
| Orgenesis Inc. | 21.78 Million USD | 715.493% |
| Entera Bio Ltd. | -10.62 Million USD | -1161.445% |
| GH Research PLC | -78.07 Million USD | -71.727% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -501.575% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -402.941% |
| Xencor, Inc. | 29.64 Million USD | 552.297% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6706.69% |
| Replimune Group, Inc. | 1.41 Million USD | 9595.68% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -54646.68% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -6.061% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -11184.829% |
| Portage Biotech Inc. | -4.98 Million USD | -2591.809% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -595939.12% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -102.775% |
| OncoCyte Corporation | -6.56 Million USD | -1942.953% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 15040.613% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2843.141% |
| Purple Biotech Ltd. | -14.13 Million USD | -848.359% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -464.401% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1948.571% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -703.245% |
| HilleVax, Inc. | -165.48 Million USD | 18.978% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5182.861% |
| Tharimmune, Inc. | -10.93 Million USD | -1126.106% |
| Genprex, Inc. | -6.73 Million USD | -1890.003% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 63.645% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -51.57% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9470.236% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3942.242% |
| OKYO Pharma Limited | -826.84 Thousand USD | -16115.677% |
| Savara Inc. | 153 Thousand USD | 87733.333% |
| Curis, Inc. | -23.88 Million USD | -461.305% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2499.483% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -17177.954% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2059.778% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11414.684% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.049% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1186.672% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 77.955% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 27.754% |
| Erasca, Inc. | -37.21 Million USD | -260.272% |
| bluebird bio, Inc. | 108.57 Million USD | 223.494% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10310.725% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 135.401% |
| DBV Technologies S.A. | -126.98 Million USD | -5.586% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10310.725% |
| Moderna, Inc. | -2.9 Billion USD | 95.388% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1195.199% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1133.704% |
| Molecular Templates, Inc. | 707 Thousand USD | 19064.498% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -327.398% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 138.683% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -63.387% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -46.167% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -315.465% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -290.037% |
| MacroGenics, Inc. | -66.98 Million USD | -100.163% |
| RenovoRx, Inc. | -1.17 Million USD | -11330.435% |
| Adicet Bio, Inc. | -138.78 Million USD | 3.392% |
| Prime Medicine, Inc. | -27.94 Million USD | -379.865% |
| Aditxt, Inc. | 18.12 Million USD | 839.914% |
| Adagene Inc. | -87.62 Million USD | -53.01% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3118.853% |
| Quantum-Si incorporated | -118.55 Million USD | -13.092% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 472.39% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1693.894% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -176.4% |
| SciSparc Ltd. | -2.06 Million USD | -6392.93% |
| Vericel Corporation | 1.27 Million USD | 10599.53% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1018.098% |
| Minerva Neurosciences, Inc. | 41 Million USD | 426.988% |
| Generation Bio Co. | 31.44 Million USD | 526.351% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 23.542% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -333.59% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 214.997% |
| Invivyd, Inc. | -198.47 Million USD | 32.446% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -48.531% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5492.011% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -89.404% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1864.527% |
| 2seventy bio, Inc. | 181.71 Million USD | 173.785% |
| ADMA Biologics, Inc. | 90.06 Million USD | 248.867% |
| Clene Inc. | 3.34 Million USD | 4114.341% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1376.202% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -523.304% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1977.91% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 61.038% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -415.695% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 175.467% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3176.96% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2780.508% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2473.987% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -2.897% |
| Evaxion Biotech A/S | 5.28 Million USD | 2636.088% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -19.109% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -2.138% |
| Trevena, Inc. | 2.25 Million USD | 6037.954% |
| Surrozen, Inc. | -32.66 Million USD | -310.479% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -160.297% |
| Cingulate Inc. | 3.08 Million USD | 4449.425% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4465.169% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1965.577% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1343.071% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -69.029% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -1.998% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -27.039% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3300.744% |
| Kronos Bio, Inc. | -36.05 Million USD | -271.884% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1525.008% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9295.29% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -147.123% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1030.045% |
| ImmunityBio, Inc. | 618.22 Million USD | 121.688% |
| Korro Bio, Inc. | -132.94 Million USD | -0.855% |
| Kineta, Inc. | -4.54 Million USD | -2852.632% |
| BioVie Inc. | -17.73 Million USD | -656.126% |
| Codexis, Inc. | -43.27 Million USD | -209.859% |
| Celularity Inc. | 65.19 Million USD | 305.674% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4130.956% |
| Celcuity Inc. | 6.78 Million USD | 2076.543% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3884.583% |
| Cibus, Inc. | -8.07 Million USD | -1559.804% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3070.466% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3033.895% |
| IN8bio, Inc. | -16.38 Million USD | -718.104% |
| Kodiak Sciences Inc. | -103.87 Million USD | -29.077% |
| Annexon, Inc. | -193.75 Million USD | 30.8% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 372541.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -666.209% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3716.652% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.718% |
| Eyenovia, Inc. | 1.25 Million USD | 10752.164% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 598.342% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4034.413% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -303.281% |
| Arcellx, Inc. | -296.95 Million USD | 54.849% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -587.373% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -127.735% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -546.881% |
| Moolec Science SA | 117.61 Thousand USD | 114097.245% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -249.173% |
| Geron Corporation | 14.76 Million USD | 1008.333% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -253.603% |
| Royalty Pharma plc | 5.65 Billion USD | 102.37% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 5.192% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1818.313% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2400.14% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 4.727% |
| Humacyte, Inc. | -22.48 Million USD | -496.278% |
| Structure Therapeutics Inc. | -124.33 Million USD | -7.833% |
| 89bio, Inc. | -289.05 Million USD | 53.614% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -431.174% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7419.854% |
| Genelux Corporation | -6.89 Million USD | -1843.456% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -331.691% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 260.383% |
| Notable Labs, Ltd. | -9.77 Million USD | -1271.512% |
| Liquidia Corporation | -80.17 Million USD | -67.231% |
| Mustang Bio, Inc. | -3.73 Million USD | -3488.838% |
| Immunovant, Inc. | -635.22 Million USD | 78.893% |
| Quantum-Si incorporated | -118.55 Million USD | -13.092% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -663.374% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3136.278% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1770.35% |
| Acasti Pharma Inc. | -23 Million USD | -482.825% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3881.879% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -725.133% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 2.658% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4202.421% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -503.09% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -622.058% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 20.794% |
| PepGen Inc. | -60.67 Million USD | -120.997% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -483.561% |
| United Therapeutics Corporation | -507.7 Million USD | 73.591% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -601.03% |
| Solid Biosciences Inc. | -47.75 Million USD | -180.794% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15452.803% |
| Immuneering Corporation | -54.94 Million USD | -144.034% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3089.708% |
| Silo Pharma, Inc. | -3.52 Million USD | -3704.406% |
| Belite Bio, Inc | -87.27 Million USD | -53.635% |
| XOMA Corporation | -29 Million USD | -362.341% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -89.653% |
| Bionomics Limited | 227 Million USD | 159.063% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -15.305% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5193.289% |
| uniQure N.V. | -102.95 Million USD | -30.236% |
| Cassava Sciences, Inc. | -121.13 Million USD | -10.685% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3118.853% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 427.413% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1020.968% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4233.236% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 126589.623% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -4034.413% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1605.66% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1707.969% |
| Altimmune, Inc. | -134.48 Million USD | 0.303% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 167.694% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5193.289% |
| Compugen Ltd. | -12.9 Million USD | -939.05% |
| Peak Bio, Inc. | 10.34 Million USD | 1396.682% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -47277.739% |
| Benitec Biopharma Inc. | -50.58 Million USD | -165.073% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -28.504% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 782.51% |
| Zura Bio Limited | -99.8 Million USD | -34.34% |
| PolyPid Ltd. | 6.17 Million USD | 2273.079% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 280.894% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 782.51% |
| Instil Bio, Inc. | 75.35 Million USD | 277.923% |
| argenx SE | -2.02 Billion USD | 93.391% |
| Immunome, Inc. | -97.02 Million USD | -38.184% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -496.039% |
| Verona Pharma plc | -220.44 Million USD | 39.177% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -86.888% |
| Shattuck Labs, Inc. | -121.42 Million USD | -10.422% |
| CervoMed Inc. | -7.79 Million USD | -1620.54% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 27.72% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2966.064% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -1.775% |
| Moolec Science SA | 117.61 Thousand USD | 114097.245% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5760.155% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 943.35% |
| AnaptysBio, Inc. | -18.15 Million USD | -638.687% |
| Design Therapeutics, Inc. | -18.15 Million USD | -638.727% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -90.505% |
| NeurAxis, Inc. | 145.7 Thousand USD | 92124.022% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1293.723% |
| Lumos Pharma, Inc. | -28.49 Million USD | -370.568% |
| Achilles Therapeutics plc | -126.92 Million USD | -5.637% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -86.888% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -20347.288% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -545.423% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9295.29% |
| Nutriband Inc. | -251.65 Thousand USD | -53178.47% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -917.986% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1702.137% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 139.412% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 664.9% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 70.036% |
| Palisade Bio, Inc. | -12.06 Million USD | -1011.49% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 4.442% |
| Beam Therapeutics Inc. | -262.72 Million USD | 48.965% |
| Neurogene Inc. | -131.95 Million USD | -1.61% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 714.59% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2647.52% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 64.453% |
| Sesen Bio, Inc. | -112.55 Million USD | -19.125% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -34.267% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5610.853% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -243.563% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -60.994% |
| Athira Pharma, Inc. | -88.99 Million USD | -50.652% |
| Vaccinex, Inc. | -1.28 Million USD | -10309.86% |
| HCW Biologics Inc. | 2.85 Million USD | 4793.532% |
| XOMA Corporation | -29 Million USD | -362.341% |
| Nektar Therapeutics | 210.24 Million USD | 163.774% |
| Arvinas, Inc. | -313.8 Million USD | 57.272% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8361.743% |
| Merus N.V. | -192.88 Million USD | 30.487% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 323.521% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1832.531% |
| Rezolute, Inc. | -68.16 Million USD | -96.689% |
| Clene Inc. | 3.34 Million USD | 4114.341% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -916.751% |
| BeyondSpring Inc. | -13.75 Million USD | -874.766% |
| Synlogic, Inc. | -6.68 Million USD | -1905.669% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11923.545% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1485.795% |
| Peak Bio, Inc. | 10.34 Million USD | 1396.682% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -62.678% |
| Krystal Biotech, Inc. | -350.23 Million USD | 61.717% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 208.019% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 20.661% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4146.845% |
| MannKind Corporation | 143.89 Million USD | 193.176% |
| Ikena Oncology, Inc. | -109.15 Million USD | -22.832% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1670.955% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -305.073% |
| Gossamer Bio, Inc. | 180.35 Million USD | 174.342% |
| CohBar, Inc. | -5.93 Million USD | -2160.75% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -350.716% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3036.465% |
| Legend Biotech Corporation | -949.39 Million USD | 85.877% |
| Mural Oncology plc | -255.84 Million USD | 47.593% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 516.201% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2746.3% |
| Disc Medicine, Inc. | -358.28 Million USD | 62.577% |
| Champions Oncology, Inc. | 4.81 Million USD | 2886.347% |
| REGENXBIO Inc. | 54.76 Million USD | 344.813% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -49760.733% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 11.22% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1387.782% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -66.18% |
| Vaxart, Inc. | -8.24 Million USD | -1526.975% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -167.196% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -5.436% |
| Cellectis S.A. | -43.85 Million USD | -205.733% |
| Longeveron Inc. | -2.9 Million USD | -4510.695% |
| Repare Therapeutics Inc. | -107.85 Million USD | -24.311% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.846% |
| Inozyme Pharma, Inc. | 12 Million USD | 1216.953% |
| Revolution Medicines, Inc. | -608.2 Million USD | 77.955% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10800.732% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 49.426% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 10.657% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -756.899% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -18018.784% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.598% |
| Denali Therapeutics Inc. | -74.86 Million USD | -79.094% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1018.098% |
| Veru Inc. | 4.77 Million USD | 2905.018% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1092.237% |
| Cingulate Inc. | 3.08 Million USD | 4449.425% |
| Passage Bio, Inc. | 4.58 Million USD | 3024.297% |
| Context Therapeutics Inc. | -14.44 Million USD | -827.893% |
| Exicure, Inc. | 5.84 Million USD | 2392.341% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 41.8% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -238.84% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 954.496% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -127.944% |
| Nuvalent, Inc. | -335.38 Million USD | 60.023% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7830.833% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -80.015% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1408.2% |
| OmniAb, Inc. | 9.2 Million USD | 1556.905% |
| Anew Medical, Inc. | 1.43 Million USD | 9460.019% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 918.465% |
| Lipocine Inc. | -4.75 Million USD | -2719.99% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -22.081% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 980.303% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -164.67% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 638.643% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1894.926% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -103.684% |
| Ocugen, Inc. | -32.52 Million USD | -312.284% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -56.68% |
| Q32 Bio Inc. | -37.94 Million USD | -253.323% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -21250.159% |
| Alumis Inc. Common Stock | -13.52 Million USD | -891.049% |
| Equillium, Inc. | -22.39 Million USD | -498.781% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -424.402% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -310.948% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -53982.649% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 200.028% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4292.589% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 40922.857% |
| Dominari Holdings Inc. | 195 Thousand USD | 68858.462% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2445.686% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1403.634% |
| Bio-Techne Corporation | 267.74 Million USD | 150.077% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -727.189% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -13.536% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1495.609% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -959.829% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 45.3% |
| Nkarta, Inc. | 57.29 Million USD | 333.999% |
| BioCardia, Inc. | 212 Thousand USD | 63344.811% |
| Iterum Therapeutics plc | 13.43 Million USD | 1097.76% |